Market By System, Applications, And Geography | Forecast 2019-2027
As per the Triton Market Research analysis, the Asia-Pacific neurostimulation device market is expected to flourish at a CAGR of 11.78% over the forecast period of 2019-2027.
Geographically, the countries studied in the Asia-Pacific neurostimulation device market are:
• China
• Japan
• India
• South Korea
• ASEAN Countries
• Australia
• Rest of Asia-Pacific
Report scope can be customized per your requirements. Request For Customization
The Asia-Pacific region is one of the most profitable markets available for the growth of neurostimulation devices. The region is expected to boom with the highest CAGR in terms of revenue during the forecasted period. An increase in lifestyle-oriented diseases, growing confidence of doctors in the use of neurostimulation devices, and developments in healthcare infrastructure are the major market drivers in the region.
In India, many state governments and foreign private organizations have been taking initiatives to contribute to the neurostimulation device market growth. For instance, according to the World Health Organization (WHO), the stroke rate accounts for 58 per 100000 individuals among the population of the country. People from the age group of 55 and above are likely to get affected by stroke in the country. This has led to an increase in the demand & adoption of neurostimulation devices in India.
Similarly, in China, the prevalence of the aging population and lifestyle diseases such as dementia drive the neurostimulation device market. According to the Ministry of Health, the number of individuals affected by dementia in China accounts for around 20% of dementia cases across the world in 2017, which is approximately 50 million. Thus, China is predicted to create the biggest market for neurostimulation devices during the forecasted years.
Boston Scientific Corporation is a leading company that manufactures, develops, and markets medical devices that are used in numerous interventional medical specialties. The company has a presence in almost every surgical segment due to its broad portfolio of products. The company provides drug-eluting coronary stent systems and intravascular catheter-directed ultrasound imaging catheters and systems. The company has its operations in Asia-Pacific, Europe, the Americas, and the Middle East and Africa.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. ASIA-PACIFIC
NEUROSTIMULATION MARKET – SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
DEFINITION
2.2. PORTER’S
FIVE FORCES MODEL
2.2.1. THREAT
OF NEW ENTRANTS
2.2.2. THREAT
OF SUBSTITUTES
2.2.3. BARGAINING
POWER OF SUPPLIERS
2.2.4. BARGAINING
POWER OF BUYERS
2.2.5. THREAT
OF RIVALRY
2.3. VALUE
CHAIN OUTLOOK
2.4. MARKET
TRENDS
2.5. MARKET
SHARE OUTLOOK
2.6. PESTLE
OUTLOOK
2.7. MARKET
ATTRACTIVENESS INDEX
2.8. KEY
INSIGHT
2.9. MARKET
DRIVERS
2.9.1. RISING
INCIDENCE OF NEURO DISEASES
2.9.2. INCREASING
GERIATRIC POPULATION
2.9.3. GROWING
DEMAND FOR MRI SCANS
2.9.4. FAVORABLE
REIMBURSEMENT POLICIES
2.10.
MARKET RESTRAINTS
2.10.1.
HIGH COST OF NEUROMODULATION TREATMENT
2.10.2.
PRESENCE OF ALTERNATIVE THERAPY
2.11.
MARKET OPPORTUNITIES
2.11.1.
HIGH MARKET POTENTIAL FOR SCS DEVICES IN
NEUROSTIMULATION
2.11.2.
TECHNOLOGICAL DEVELOPMENT
2.11.3.
GROWING INCIDENCE OF CHRONIC DISCOMFORT
2.12.
MARKET CHALLENGES
2.12.1.
STRINGENT REGULATORY APPROVALS
2.12.2.
SIDE-EFFECTS OF ASSOCIATED NEUROSTIMULATION
DEVICES
3. NEUROSTIMULATION
DEVICE MARKET OUTLOOK – BY SYSTEM
3.1. SPINAL
CORD STIMULATORS (SCS)
3.2. DEEP
BRAIN STIMULATORS (DBS)
3.3. SACRAL
NERVE STIMULATORS (SNS)
3.4. VAGUS
NERVE STIMULATORS (VNS)
3.5. GASTRIC
ELECTRIC STIMULATOR
3.6. OTHER
SYSTEMS
4. NEUROSTIMULATION
DEVICE MARKET OUTLOOK – BY APPLICATIONS
4.1. PAIN
MANAGEMENT
4.2. EPILEPSY
4.3. ESSENTIAL
TREMOR
4.4. URINARY
AND FECAL INCONTINENCE
4.5. DEPRESSION
4.6. DYSTONIA
4.7. GASTROPARESIS
4.8. PARKINSON’S
DISEASE
4.9. OTHER
APPLICATIONS
5. NEUROSTIMULATION
DEVICE MARKET – REGIONAL OUTLOOK
5.1.1. COUNTRY
ANALYSIS
5.1.1.1. INDIA
5.1.1.2. CHINA
5.1.1.3. JAPAN
5.1.1.4. AUSTRALIA
& NEW ZEALAND
5.1.1.5. SOUTH
KOREA
5.1.1.6. ASEAN
COUNTRIES
5.1.1.7. REST
OF ASIA-PACIFIC
6. COMPANY
PROFILES
6.1. NEURONETICS,
INC.
6.2. ST.
JUDE MEDICAL, INC. (ACQUIRED BY ABBOTT LABORATORIES)
6.3. HOCOMA
AG
6.4. NEVRO
CORP.
6.5. CYBERONICS
INC.
6.6. COGENTIX
MEDICAL, INC.
6.7. DEPUY
SYNTHES COMPANIES
6.8. DR.
LANGER MEDICAL GMBH
6.9. MEDTRONIC
PLC
6.10.
THE MAGSTIM COMPANY LIMITED
6.11.
ECTRON LIMITED
6.12.
BOSTON SCIENTIFIC CORPORATION
6.13.
EKSO BIONICS HOLDING INC.
6.14.
ALEVA NEUROTHERAPEUTICS SA
6.15.
HELIUS MEDICAL TECHNOLOGIES
7. RESEARCH
METHODOLOGY & SCOPE
7.1. RESEARCH
SCOPE & DELIVERABLES
7.1.1. OBJECTIVES
OF STUDY
7.1.2. SCOPE
OF STUDY
7.2. SOURCES
OF DATA
7.2.1. PRIMARY
DATA SOURCES
7.2.2. SECONDARY
DATA SOURCES
7.3. RESEARCH
METHODOLOGY
7.3.1. EVALUATION
OF PROPOSED MARKET
7.3.2. IDENTIFICATION
OF DATA SOURCES
7.3.3. ASSESSMENT
OF MARKET DETERMINANTS
7.3.4. DATA
COLLECTION
7.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1 ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET 2019-2027 ($
MILLION)
TABLE 2 ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET BY SYSTEM
2019-2027 ($ MILLION)
TABLE 3 ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET BY APPLICATIONS
2019-2027 ($ MILLION)
TABLE 4 ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET BY COUNTRY
2019-2027 ($ MILLION)
FIGURE 1 ASIA-PACIFIC NEUROSTIMULATION DEVICE
MARKET 2019-2027 ($ MILLION)
FIGURE 2 VALUE CHAIN OUTLOOK
FIGURE 3 NEUROSTIMULATION DEVICE COMPANY MARKET
SHARE OUTLOOK 2018 (%)
FIGURE 4 ASIA-PACIFIC NEUROSTIMULATION DEVICE
MARKET BY SPINAL CORD STIMULATORS 2019-2027 ($ MILLION)
FIGURE 5 ASIA-PACIFIC NEUROSTIMULATION DEVICE
MARKET BY DEEP BRAIN STIMULATORS 2019-2027 ($ MILLION)
FIGURE 6 ASIA-PACIFIC NEUROSTIMULATION DEVICE
MARKET BY SACRAL NERVE STIMULATORS 2019-2027 ($ MILLION)
FIGURE 7 ASIA-PACIFIC NEUROSTIMULATION DEVICE
MARKET BY VAGUS NERVE STIMULATORS 2019-2027 ($ MILLION)
FIGURE 8 ASIA-PACIFIC NEUROSTIMULATION DEVICE
MARKET BY GASTRIC ELECTRIC STIMULATOR 2019-2027 ($ MILLION)
FIGURE 9 ASIA-PACIFIC NEUROSTIMULATION DEVICE
MARKET BY OTHER SYSTEM 2019-2027 ($ MILLION)
FIGURE 10 ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET
BY PAIN MANAGEMENT 2019-2027 ($ MILLION)
FIGURE 11 ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET
BY EPILEPSY 2019-2027 ($ MILLION)
FIGURE 12 ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET
BY ESSENTIAL TREMOR 2019-2027 ($ MILLION)
FIGURE 13 ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET
BY URINARY AND FECAL INCONTINENCE 2019-2027 ($ MILLION)
FIGURE 14 ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET
BY DEPRESSION 2019-2027 ($ MILLION)
FIGURE 15 ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET
BY DYSTONIA 2019-2027 ($ MILLION)
FIGURE 16 ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET
BY GASTROPARESIS 2019-2027 ($ MILLION)
FIGURE 17 ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET
BY PARKINSON’S DISEASE 2019-2027 ($ MILLION)
FIGURE 18 ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET
BY OTHER APPLICATIONS 2019-2027 ($ MILLION)
FIGURE 19 INDIA NEUROSTIMULATION DEVICE MARKET
2019-2027 ($ MILLION)
FIGURE 20 CHINA NEUROSTIMULATION DEVICE MARKET
2019-2027 ($ MILLION)
FIGURE 21 JAPAN NEUROSTIMULATION DEVICE MARKET
2019-2027 ($ MILLION)
FIGURE 22 AUSTRALIA & NEW ZEALAND NEUROSTIMULATION
DEVICE MARKET 2019-2027 ($ MILLION)
FIGURE 23 SOUTH KOREA NEUROSTIMULATION DEVICE MARKET
2019-2027 ($ MILLION)
FIGURE 24 ASEAN COUNTRIES NEUROSTIMULATION DEVICE
MARKET 2019-2027 ($ MILLION)
FIGURE 25 REST OF ASIA-PACIFIC NEUROSTIMULATION DEVICE
MARKET 2019-2027 ($ MILLION)